Our Latest News - BUHLMANN

BUHLMANN News

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Sala E et al.; Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy. J Neurol Sci. 2014 Oct 15; 345(1-2):224-7. PMID:25115501 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Prevalence, specificity and functionality of anti-ganglioside antibodies in Neuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2014 Mar 15; 268(1-2): 89-94. PMID:24529728 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Polyneuropathy with Anti-sulfatide and Anti-MAG Antibodies: Clinical, Neurophysiological, Pathological Features and Response to Treatment

Anti-MAG Autoantibodies ELISA Citation: Campagnolo M et al.; Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. J Neuroimmunol. 2015 Apr 15; 281:1-4. PMID:25867460 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies

Anti-MAG Autoantibodies ELISA Citation: Magy L et al.; Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies; J Immunol Res. 2015;2015: 450391. doi: 10.1155/2015/450391. Epub 2015 May 6. PMID:26065001 Anti-MAG Autoantibodies ELISA  is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Fcγ Receptor IIIA Genotype is Associated with Rituximab Response in Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Fcγ receptor IIIA genotype is associated with rituximab response in anti-myelin-associated glycoprotein neuropathy. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8): 918-20.PMID:24487381 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Long-term Efficacy of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Neuropathy: RIMAG Follow-up Study; Journal of the Peripheral Nervous System

Anti-MAG Autoantibodies ELISA Citation: Ferfoglia R I et al.; Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study; Journal of the Peripheral Nervous System 21:10–14 (2016)PMID:26748872 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Classical and Lectin Complement Pathway Activity in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citations: Stork AC et al.; Classical and lectin complement pathway activity in polyneuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2016 Jan 15; 290:76-9. PMID:26711574 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Anti-ganglioside Antibodies were not Detected in Human Subjects Infected with or Vaccinated Against 2009 Pandemic Influenza A (H1N1) Virus

Anti-GM1 Autoantibodies ELISA Citation: Lei T et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine. 2012 Mar 30; 30(16):2605-10.PMID:22342549 Highlight from this Publication "Anti-ganglioside antibodies, which might be associated with the development of GBS, were previously reported to be induced in mice
Continue Reading

The Presence of Mycoplasma Pneumoniae Infection and GM1 Ganglioside Antibodies in Guillain-Barré Syndrome

BÜHLMANN GanglioCombi ELISA Citation: Sharma MB et al.: The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome. J Infect Dev Ctries. 2011 Jul 4; 5(6):459-64. PMID:21727645.   Highlight from this Publication "Significant difference in levels of anti GM1 ganglioside antibodies (IgG & IgM) was seen between GBS patients and non-neurological controls, highlighting
Continue Reading

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited

BÜHLMANN GanglioCombi® MAG ELISA Citation Kollewe K et al.; Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited. PLoS One. 2015 Apr 14; 10(4):e0125339.     Highlight from this Publication "In the present study, we describe for the first time the utilization of a state of the art-ELISA assay to obtain reliable data on the occurrence of IgG
Continue Reading